Gennev
Gennev Founder Jill Angelo Steps Down After Acquisition; Aurion Biotech CEO Replaced Following Alcon Majority Stake; Temporal Adds New Leadership
Jill Angelo, founder and CEO of menopause startup Gennev, stepped down following its acquisition by Unified Women’s Healthcare, while Aurion Biotech replaced CEO Greg Kunst with Arnaud Lacoste after Alcon acquired a majority stake. Temporal also announced leadership additions with Jim Cyb as president and Sahir Azam as an independent board member.
Unified Women’s Healthcare Acquires Menopause Telehealth Startup Gennev to Expand Care Network
Unified Women’s Healthcare acquired Seattle telehealth startup Gennev, which focuses on menopause care, allowing Gennev to scale further within a large network of specialists. Gennev, founded by Jill Angelo in 2016, offers products and services for perimenopause and menopause, operating independently within the Florida-based parent company's platform.
Jill Angelo
CEO of Gennev, Jill Angelo, is changing the stigma associated with women’s health in the second half of their life with the first-ever online clinic for women in menopause. Prior to starting Gennev, Jill had a 20-year career in tech, with 15 of those years at Microsoft in executive roles. During this episode, Jill shares details of her life growing up on a farm, her background in speech communication, how the idea for Gennev came to be during her sabbatical and the impact being on The NBC Today Show had on the business. We also have an open conversation with…
